There is significant heterogeneity in formulary placement and restrictions on new drug approvals in the Part D marketplace.
Danya Qato, PhD
Advertisement
Articles by Danya Qato, PhD
Advertisement
Latest Updated Articles
- Placement of Selected New FDA-Approved Drugs in Medicare Part D Formularies, 2009-2013
Published: June 6th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
2
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
3
Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color
4
Stronger Primary Care, Oncology Partnerships May Improve Patient Outcomes: Mark Fendrick, MD
5
